Company intelligence / Profile preview

Solar Biotech

Norton, Virginia, United Statessolarbiotech.com ↗

Ownership: Private
Development stage: Commercial

Overview

Solar Biotech specialized in providing end-to-end sustainable synthetic biology product development and contract manufacturing services using proprietary modular plant technology ("BioNodes") powered by renewable energy sources. The company developed products via precision fermentation for industrial biotech markets including foodtech. It ceased active operations after entering bankruptcy proceedings in June 2024 with its assets up for sale. No clinical results as the company was not focused on human therapeutics.

Modalities: Precision fermentationMicrobial fermentationProtein productionEnzyme production
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on Solar Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Solar Biotech.

Explore the full profile